|Title: ||The breast cancer genome - a key for better oncology|
|Authors: ||Vollan, Hans Kristian Moen|
|Issue Date: ||30-Nov-2011|
|Abstract: ||Abstract Molecular classification has added important knowledge to breast cancer biology, but has yet to be implemented as a clinical standard. Full sequencing of breast cancer genomes could potentially refine classification and give a more complete picture of the mutational profile of cancer and thus aid therapy decisions. Future treatment guidelines must be based on the knowledge derived from histopathological sub-classification of tumors, but with added information from genomic signatures when properly clinically validated. The objective of this article is to give some background on molecular classification, the potential of next generation sequencing, and to outline how this information could be implemented in the clinic.|
|Description: ||RIGHTS : This article is licensed under the BioMed Central licence at http://www.biomedcentral.com/about/license which is similar to the 'Creative Commons Attribution Licence'. In brief you may : copy, distribute, and display the work; make derivative works; or make commercial use of the work - under the following conditions: the original author must be given credit; for any reuse or distribution, it must be made clear to others what the license terms of this work are.|
|Other Identifiers: ||http://dx.doi.org/10.1186/1471-2407-11-501|
|Appears in Collections:||Scholarly works - Oncology|
This item has been accessed 386 times.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.